Catherine Rutten,

Catherine Rutten,


Catherine Rutten is CEO of, the association of 130+ innovative pharmaceutical companies in Belgium. She has extensive experience as Director in highly regulated sectors such as the post and telecommunications sectors, both from a company perspective (Loeff Claeys Verbeke, British Telecom), and from the authorities’ perspective (as member of the Council of the Belgian Institute for Postal Services and Telecommunications). Catherine Rutten holds a Law degree at the University of Leuven (KUL), as well as a LL.M. of the College of Europe and the London School of Economics.

Twitter: @RuttenCatherine
Company Twitter: @pharmabe


OPENING KEYNOTE: Pharma and innovation: the Belgian pharma ecosystem

Belgian exports in pharmaceuticals and vaccines are thriving thanks to a unique Belgian pharma ecosystem, in which groundbreaking research into new therapies by 200+ large and small pharma companies are supported by excellent service provisions of logistics partners. The country is gifted with its central location on the European continent and, thanks to clever investments, […]